Management of Acute Bacterial Sinusitis in Children

Clinical Diagnosis

• Persistent acute bacterial sinusitis is diagnosed when a child has purulent nasal discharge lasting >10 days, accompanied by daytime cough and low‑grade fever. This definition follows the American Academy of Pediatrics (AAP) criteria. 1

• The diagnosis is entirely clinical; routine imaging is not required to confirm acute bacterial sinusitis. 2

Role of Imaging

• The American College of Radiology (ACR) Appropriateness Criteria state that sinus X‑rays are not recommended for uncomplicated acute bacterial sinusitis because imaging does not change management. 2

• More than 50 % of children with viral upper‑respiratory infections show abnormal sinus radiographs, and 42 % of healthy children have sinus abnormalities on imaging, underscoring the low specificity of radiographs. 2

• Imaging is reserved only for cases where orbital or intracranial complications are suspected (e.g., periorbital swelling, proptosis, severe headache, neurologic signs). 2

Indications for Antibiotic Therapy

• AAP guidelines allow either antibiotic therapy or a 3‑day observation period for persistent acute bacterial sinusitis without complications; however, antibiotic treatment is strongly favored when symptom duration exceeds the 10‑day threshold. 1

• The number needed to treat (NNT) with antibiotics is 3–5 to achieve clinical cure, indicating a substantial benefit over no antibiotics. 1

First‑Line Antibiotic Choice

• Oral amoxicillin is the first‑line agent for uncomplicated acute bacterial sinusitis in children, dosed at 45 mg/kg/day (standard) or 80–90 mg/kg/day (high‑dose) when needed. 1

• The most common bacterial pathogens and their approximate prevalence are:

  • Streptococcus pneumoniae – ~30 %
  • Non‑typeable Haemophilus influenzae – ~30 %
  • Moraxella catarrhalis – ~10 %

Supportive Care

• Supportive/symptomatic care alone is not appropriate once symptoms have persisted >10 days, because the condition is bacterial rather than viral and antibiotics provide higher cure rates. [1][3]

Monitoring After Initiating Amoxicillin

• Re‑evaluate the child 72 hours after starting amoxicillin for:
  
  • Worsening symptoms (new fever, increased discharge, severe headache) indicating possible treatment failure. 1
  • Lack of improvement, which may warrant escalation to high‑dose amoxicillin‑clavulanate. 1
  • Signs of orbital complications (periorbital swelling, proptosis, ophthalmoplegia) that require immediate imaging per ACR criteria. 2
  • Signs of intracranial complications (altered mental status, severe headache, focal neurologic deficits) that necessitate emergent CT and specialist consultation. 4

Management of Persistent Acute Bacterial Sinusitis in Children

Definition and Indication for Antibiotic Therapy

• Persistent acute bacterial sinusitis is defined by ≥10 days of purulent nasal discharge with daytime cough and fever without improvement; this meets the American Academy of Pediatrics (AAP) criteria and mandates antibiotic treatment rather than watchful waiting. 5

First‑Line Antibiotic Regimen

• The AAP recommends oral amoxicillin 45 mg/kg/day divided twice daily as the first‑line therapy for uncomplicated persistent acute bacterial sinusitis in children. 5
• The recommended treatment course is 10–14 days, or until the child is symptom‑free for at least 7 days. 5

When to Use High‑Dose or Alternative Antibiotics

• High‑dose amoxicillin (80–90 mg/kg/day) is reserved for children with risk factors such as age < 2 years, daycare attendance, recent antibiotic use (past 4–6 weeks), or residence in areas with high prevalence of resistant Streptococcus pneumoniae; children without these risk factors should receive standard dosing initially. 5
• The AAP advises escalating to amoxicillin‑clavulanate (high‑dose) only if the child fails to improve after 72 hours of standard amoxicillin therapy. 5

Imaging Recommendations

• The AAP and the American College of Radiology (ACR) state that sinus X‑rays are not indicated for uncomplicated acute bacterial sinusitis because imaging does not change management. 5
• Imaging is reserved exclusively for suspected complications (e.g., periorbital swelling, proptosis, severe headache, altered mental status, or focal neurologic signs). 5

Monitoring and Escalation

• Reassessment at 72 hours after initiating amoxicillin is recommended to identify worsening symptoms or lack of improvement, which would prompt escalation to high‑dose amoxicillin‑clavulanate. 5
• Clinicians should watch for orbital (periorbital swelling, proptosis, ophthalmoplegia) or intracranial (altered mental status, severe headache, focal neurologic deficits) complications; their presence requires immediate imaging and specialist referral. 5

Common Pitfalls to Avoid

• Do not delay antibiotic therapy once symptoms exceed 10 days; although the AAP permits a brief (≤3‑day) observation period for persistent cases, treatment should be initiated promptly after the 10‑day threshold. 5
• Do not obtain sinus imaging in uncomplicated cases, as the diagnosis is clinical and imaging will not alter management. 5
• Do not prescribe intranasal corticosteroids as monotherapy; they are adjuncts and lack antibacterial activity. (No citation; omitted)
• Do not start with amoxicillin‑clavulanate unless risk factors for resistant organisms are present; standard amoxicillin remains first‑line for uncomplicated disease. 5

Management of Persistent Acute Bacterial Sinusitis in Young Children

Diagnostic Criteria (American Academy of Pediatrics)

Distinguishing Bacterial from Viral Upper Respiratory Infection (AAP)

Indications for Antibiotic Therapy (AAP)

Role of Antibiotics in Early vs. Late Disease (European Position Paper)

First‑Line Antibiotic Regimen (AAP)

When to Escalate to High‑Dose Therapy (AAP)

Follow‑up and Reassessment (AAP)

Imaging Recommendations (AAP)

Common Pitfalls to Avoid (AAP)

Management of Acute Bacterial Sinusitis in Children

Diagnostic Approach

• The American Academy of Pediatrics (AAP) states that the diagnosis of uncomplicated acute bacterial sinusitis in children is made entirely on clinical grounds; routine sinus imaging (X‑ray or CT) is not recommended because it does not alter management. 11
• Clinical criteria that define acute bacterial sinusitis in a 12‑year‑old include any one of the following patterns:
  
  • Persistent illness – nasal discharge or daytime cough lasting >10 days without improvement.
  • Worsening course – new fever ≥38 °C after an initial period of improvement.
  • Severe onset – fever ≥39 °C plus purulent nasal discharge for ≥3 consecutive days.

First‑Line Antimicrobial Therapy

• The AAP recommends standard‑dose amoxicillin (45 mg/kg/day divided twice daily) as the first‑line oral antibiotic for uncomplicated acute bacterial sinusitis, administered for 10–14 days or until the child is symptom‑free for at least 7 days. 11
• Evidence from pediatric trials shows a number needed to treat (NNT) of 3–5 with antibiotics to achieve clinical cure, indicating a substantial benefit over observation alone. 12

Risk‑Based Escalation to High‑Dose Therapy

• High‑dose amoxicillin (80–90 mg/kg/day) or amoxicillin‑clavulanate should be used when any of the following risk factors are present: recent antibiotic use within the past 4–6 weeks, attendance at daycare, or residence in an area with a high prevalence of penicillin‑resistant Streptococcus pneumoniae. (These risk factors are identified by the AAP.) 12

Mandatory 72‑Hour Reassessment

• The AAP advises a formal reassessment exactly 72 hours after initiating amoxicillin to detect treatment failure or complications. 11
• If the child exhibits worsening symptoms (new fever, increased purulent discharge, severe headache) at the 72‑hour mark, therapy should be escalated immediately to high‑dose amoxicillin‑clavulanate (90 mg/kg/day of the amoxicillin component). 12

Management of Complications

• Development of orbital signs (periorbital swelling, proptosis, impaired eye movements) warrants urgent contrast‑enhanced CT imaging and specialist (ophthalmology/ENT) consultation, as recommended by the AAP. 11

Microbiologic Considerations

Clinical Pitfalls to Avoid

• Do not postpone antibiotic therapy once the clinical diagnosis is confirmed; the AAP allows a brief 3‑day observation only when symptoms have persisted exactly 10 days and there are no severe or worsening features. 11, 12
• Do not obtain sinus imaging in uncomplicated cases; imaging is reserved solely for suspected orbital or intracranial complications. 11